Phase I clinical trial of CD19‐targeted 19‐28z/4‐1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter transformation Meeting Abstract
| Authors: | Batlevi, C. L.; Palomba, M. L.; Park, J.; Mead, E.; Santomasso, B.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R.; Yang, J.; Kane, P.; Hall, M.; Bernal, Y.; Lund, N.; Diamonte, C.; Pineda, J.; Halton, E.; Moskowitz, C.; Younes, A.; Sadelain, M.; Brentjens, R. |
| Abstract Title: | Phase I clinical trial of CD19‐targeted 19‐28z/4‐1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter transformation |
| Meeting Title: | 15th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 37 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Jun 18-22 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-06-01 |
| Start Page: | 166 |
| End Page: | 167 |
| Language: | English |
| ACCESSION: | 136932426 |
| DOI: | 10.1002/hon.124_2629 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| PUBMED: | 31187525 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 118 -- Source: cin20 |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work